Nancy A Otieno1, Fauzia A Malik2, Stacy W Nganga2, Winnie N Wairimu3, Dominic O Ouma3, Godfrey M Bigogo4, Sandra S Chaves5, Jennifer R Verani6, Marc-Alain Widdowson6, Andrew D Wilson2, Irina Bergenfeld2, Ines Gonzalez-Casanova2, Saad B Omer7. 1. Division of Global Health Protection, Centre for Global Health Research, Kenya Medical Research Institute, PO Box 1578-40100, Kisumu, Kenya. Notieno@kemricdc.org. 2. Hubert Department of Global Health, Rollins School of Public Health, Emory University, 1518 Clifton Rd NE, Atlanta, GA, 30322, USA. 3. Centre for Global Health Research, Kenya Medical Research Institute, PO Box 1578-40100, Kisumu, Kenya. 4. Division of Global Health Protection, Centre for Global Health Research, Kenya Medical Research Institute, PO Box 1578-40100, Kisumu, Kenya. 5. National Center for Immunization and Respiratory Diseases, Centers for Disease Control and Prevention, PO Box 606-00621, Nairobi, Kenya. 6. Division of Global Health Protection, Center for Global Health, Centers for Disease Control and Prevention, PO Box 606-00621, Nairobi, Kenya. 7. Department of Medicine, Division of Pediatrics, Emory University School of Medicine, 1518 Clifton Rd NE, Atlanta, GA, 30322, USA.
Abstract
BACKGROUND: Maternal immunization is a key strategy for reducing morbidity and mortality associated with infectious diseases in mothers and their newborns. Recent developments in the science and safety of maternal vaccinations have made possible development of new maternal vaccines ready for introduction in low- and middle-income countries. Decisions at the policy level remain the entry point for maternal immunization programs. We describe the policy and decision-making process in Kenya for the introduction of new vaccines, with particular emphasis on maternal vaccines, and identify opportunities to improve vaccine policy formulation and implementation process. METHODS: We conducted 29 formal interviews with government officials and policy makers, including high-level officials at the Kenya National Immunization Technical Advisory Group, and Ministry of Health officials at national and county levels. All interviews were recorded and transcribed. We analyzed the qualitative data using NVivo 11.0 software. RESULTS: All key informants understood the vaccine policy formulation and implementation processes, although national officials appeared more informed compared to county officials. County officials reported feeling left out of policy development. The recent health system decentralization had both positive and negative impacts on the policy process; however, the negative impacts outweighed the positive impacts. Other factors outside vaccine policy environment such as rumours, sociocultural practices, and anti-vaccine campaigns influenced the policy development and implementation process. CONCLUSIONS: Public policy development process is complex and multifaceted by its nature. As Kenya prepares for introduction of other maternal vaccines, it is important that the identified policy gaps and challenges are addressed.
BACKGROUND: Maternal immunization is a key strategy for reducing morbidity and mortality associated with infectious diseases in mothers and their newborns. Recent developments in the science and safety of maternal vaccinations have made possible development of new maternal vaccines ready for introduction in low- and middle-income countries. Decisions at the policy level remain the entry point for maternal immunization programs. We describe the policy and decision-making process in Kenya for the introduction of new vaccines, with particular emphasis on maternal vaccines, and identify opportunities to improve vaccine policy formulation and implementation process. METHODS: We conducted 29 formal interviews with government officials and policy makers, including high-level officials at the Kenya National Immunization Technical Advisory Group, and Ministry of Health officials at national and county levels. All interviews were recorded and transcribed. We analyzed the qualitative data using NVivo 11.0 software. RESULTS: All key informants understood the vaccine policy formulation and implementation processes, although national officials appeared more informed compared to county officials. County officials reported feeling left out of policy development. The recent health system decentralization had both positive and negative impacts on the policy process; however, the negative impacts outweighed the positive impacts. Other factors outside vaccine policy environment such as rumours, sociocultural practices, and anti-vaccine campaigns influenced the policy development and implementation process. CONCLUSIONS: Public policy development process is complex and multifaceted by its nature. As Kenya prepares for introduction of other maternal vaccines, it is important that the identified policy gaps and challenges are addressed.
Authors: Frank O Odhiambo; Kayla F Laserson; Maquins Sewe; Mary J Hamel; Daniel R Feikin; Kubaje Adazu; Sheila Ogwang; David Obor; Nyaguara Amek; Nabie Bayoh; Maurice Ombok; Kimberly Lindblade; Meghna Desai; Feiko ter Kuile; Penelope Phillips-Howard; Anna M van Eijk; Daniel Rosen; Allen Hightower; Peter Ofware; Hellen Muttai; Bernard Nahlen; Kevin DeCock; Laurence Slutsker; Robert F Breiman; John M Vulule Journal: Int J Epidemiol Date: 2012-08 Impact factor: 7.196
Authors: Daniel R Feikin; Beatrice Olack; Godfrey M Bigogo; Allan Audi; Leonard Cosmas; Barrack Aura; Heather Burke; M Kariuki Njenga; John Williamson; Robert F Breiman Journal: PLoS One Date: 2011-01-18 Impact factor: 3.240
Authors: Allison L Friedman; Kelvin O Oruko; Melissa A Habel; Jessie Ford; Jennine Kinsey; Frank Odhiambo; Penelope A Phillips-Howard; Susan A Wang; Tabu Collins; Kayla F Laserson; Eileen F Dunne Journal: BMC Public Health Date: 2014-08-16 Impact factor: 3.295
Authors: Stacy W Nganga; Nancy A Otieno; Maxwell Adero; Dominic Ouma; Sandra S Chaves; Jennifer R Verani; Marc-Alain Widdowson; Andrew Wilson; Irina Bergenfeld; Courtni Andrews; Vincent L Fenimore; Ines Gonzalez-Casanova; Paula M Frew; Saad B Omer; Fauzia A Malik Journal: BMC Health Serv Res Date: 2019-10-24 Impact factor: 2.655